Patent Assignment
Reel/Frame 050612/0115
Assignment of Assignor's Interest
Recorded: 2019-10-03
Pages: 3
Assignor
ARIKAWA, YUKA
Executed: 2019-08-29
Assignee
SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
6-8, DOSHO-MACHI 2-CHOME, CHUO-KU, OSAKA-SHI, OSAKA, 541-0045, JAPAN
Covered Property
(1)
Methods for Treating Diseases Associated with Abnormal ACVR1 Expression and ACVR1 Inhibitors for Use in the Same
PCT:
PCT/US2019/043738 ↗
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 3, 2019
From: WARNER, STEVEN L.; BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050611/0952 →
Assignment of Assignor's Interest
Oct 3, 2019
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 050612/0176 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0344 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0663 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →